NorthWest Biotherapeutics Inc (NWBO)

[jm100]

MHRA decision imminent, approval = $10.00+
FDA approval = $50.00+ using standard biotech multiple of 15 times forward looking PE.
Big pharmaceutical is not sleeping on the wheel, talks behind the scenes could materialize any moment now.

$NWBO ASCO just out: In an externally controlled phase III trial reported in JAMA Oncology, Liau et al found that the addition of an autologous tumor lysate–loaded dendritic cell vaccine (DCVax-L) to standard of care improved survival in patients with newly diagnosed glioblastoma and recurrent glioblastoma compared with contemporaneous external control patients receiving standard of care.
$NWBO Gap filled touch boom on very heavy volume. We could get MHRA approval news today then Kaboom $10.00+